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Human papillomavirus replication initiator, the E1
helicase, binds weakly to the origin of DNA replication.
Purified human chaperone proteins Hsp70 and Hsp40
(HDJ-1 and HDJ-2) independently and additively en-
hanced E1 binding to the origin. The interaction be-
tween E1 and Hsp70 was transient and required ATP
hydrolysis, whereas Hsp40 bound to E1 directly and re-
mained in the complex. A peptide of 20 residues span-
ning the HPD loop and helix II of the J domain of YDJ-1
also stimulated E1 binding to the origin, alone or in
combination with Hsp70 or Hsp40. A mutated peptide
(H34Q) had a reduced activity, while an adjacent or an
overlapping peptide had no effect. Neither Hsp70 nor
the J peptide altered the E1/DNA ratio in the complex.
Electron microscopy showed that E1 mainly bound to
DNA as a hexamer. In the presence of Hsp40, E1 primar-
ily bound to DNA as a dihexamer. Preincubation of
chaperones with viral E1 and template shortened the
lag time and increased replication in a cell-free system.
Since two helicases are essential for bidirectional repli-
cation of human papillomavirus DNA, these results dem-
onstrate that, as in prokaryotes, chaperones play an
important role in the assembly of preinitiation com-
plexes on the origin.
Molecular chaperones regulate many cellular processes such
as protein folding and translocation and the assembly and
disassembly of multiprotein complexes (reviewed in Ref. 1).
Two major Escherichia coli chaperones DnaK and DnaJ were
originally identified as genes required for the initiation of bac-
terial or bacteriophage DNA replication. Mutations in DnaK
and DnaJ lead to defects in DNA and RNA synthesis, cell
division, and proteolysis (for reviews, see Refs. 2–4). DnaK is a
weak ATPase with the ability to bind unfolded polypeptides (5,
6). DnaJ functions as a dimer (7, 8) and is considered a co-
chaperone, since it dramatically stimulates the ATPase activity
of DnaK in the presence of GrpE (6, 9). Together, these proteins
facilitate the binding of the replication initiator protein to the
origin (ori) and the initiation of DNA replication (Ref. 7; for
reviews, see Refs. 10–14).
The families of eukaryotic heat shock protein 70 (Hsp70/
Hsc70) and heat shock protein 40 (Hsp40) have a high degree of
homology to DnaK and DnaJ, respectively. Hsp70 and Hsp40
proteins are co-localized to the cytosol and also function in the
nucleus (15, 16). As in prokaryotes, the Hsp40 proteins func-
tion as co-chaperones of Hsp70, but they also have weak, inde-
pendent activity (5, 7, 17–20). All of the DnaJ homologues, such
as HDJ-1, HDJ-2, and YDJ-1, members of the human and yeast
Hsp40 family, have a conserved J domain at the amino termi-
nus. Truncated E. coli or YDJ-1 containing only the J domain is
sufficient to modulate the ATPase activity of DnaK/Hsp70 (20,
21). The corresponding J domain of the human Hsp40 proteins
is also thought to mediate interactions with Hsp70 and regu-
late its ATPase activity (for a review, see Ref. 8). Within the J
domain, there is a highly conserved HPD tripeptide loop
flanked by two a-helices, designated helix II and helix III
(22–25). Mutations in the HPD motif or in the external faces of
the a-helices significantly reduce its activity (21, 26–28). Re-
cent evidence suggests that helix II interacts with Hsp70 and
that peptides encompassing helix II and the HPD loop inhibit
the co-chaperone function of DnaJ/Hsp40, presumably because
they compete for binding to Hsp70 (28, 29).
A connection between chaperone proteins and eukaryotic
DNA replication was found recently. SV40 and polyomavirus
DNA replication require the viral large T antigen (Tag),1 which
serves as the initiator (for a review, see Ref. 30). In addition,
the SV40 Tag is also the viral oncoprotein capable of transform-
ing cells. The amino-terminal domain shared by the large,
small, and tiny Tag of the SV40/polyomaviruses exhibits a
sequence and functional homology with the J domain of the
Hsp40 family (31–36). The J domain, especially the HPD tri-
peptide loop, of the SV40 Tag plays a critical role in interacting
with the Hsc70 (31, 33), stimulating its ATPase activity (35,
36). This interaction is proposed to promote efficient viral DNA
replication (33) and also correlates with its transforming abil-
ity (35, 37), suggestive of a role of chaperone function in eu-
karyotic DNA replication. But the mechanisms of the Tag J
domain function are not understood.
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As do SV40 and polyomaviruses, the papillomaviruses have
served as model systems for eukaryotic DNA replication. Hu-
man papillomaviruses (HPVs) are prevalent and medically sig-
nificant human pathogens (for a review, see Ref. 38). To sup-
port HPV ori replication, the virus supplies two proteins, E1
and E2, while the host cell provides all other known replication
proteins, including DNA polymerases a and d, replication pro-
tein-A, replication factor-C, proliferating cell nuclear antigen,
and topoisomerases (for reviews, see Refs. 39 and 40). The
partition of the HPV replication activities into two proteins
simplifies their functional dissections relative to the Tag of
SV40/polyomavirus. To this end, we and others have estab-
lished cell-free replication systems for HPV or bovine papillo-
mavirus type 1 (BPV-1) ori plasmids by using human 293 cell
or mouse cell extracts supplemented with E1 and E2 proteins
purified from insect cells infected with recombinant baculovi-
ruses (41, 42) or have used bacterially expressed proteins
(43–45).2
Both the E1 and E2 proteins are necessary for initiation of
replication, but only E1 is additionally required for elongation
(46). The E1 protein is analogous to the SV40/polyomavirus
Tag in its role during replication. It has specific as well as
nonspecific DNA binding activities, and it is an ATPase and
helicase (46–51). The E1 protein also interacts with the 180-
kDa catalytic subunit and the 70-kDa subunit of the DNA
polymerase a (52, 53),3 thereby recruiting the host replication
machinery to the ori. The E2 protein binds to its cognate
binding sites (E2BS) in the ori, which consists of one E1BS and
several copies of E2BS, and is located within the viral enhancer
and promoter region. The bound E2 protein helps recruit E1 to
the origin (39, 40). In addition, E2 protein, in its role as a
transcription factor, excludes nucleosome formation over the
ori, facilitating the assembly of the initiation complex (54).
However, neither the E1 nor the E2 protein has a J domain.
In this report, we tested the hypothesis that host chaperone
proteins are involved in the initiation of HPV DNA replication,
as shown for bacteriophages. Our results demonstrate that
these chaperones function independently and additively to fa-
cilitate the association between the E1 protein and the ori as
demonstrated by electrophoretic mobility shift assays (EM-
SAs). Hsp70 interacts with E1 transiently and requires ATP
hydrolysis. In contrast, Hsp40 or a 20- amino acid-long J pep-
tide remains associated with E1 independent of ATP, and this
is the first example of the J domain of Hsp40 specifically
associating with a protein with ATPase activity other than
Hsp70/Hsc70. Electron microscopic examination of the E1-ori
DNA complexes demonstrates that, in the presence or absence
of Hsp70 or the J peptide, the majority of the E1 bound to ori
DNA has a size corresponding to a hexameric complex. Strik-
ingly, Hsp40 promotes an efficient formation of a bilobed mul-
timeric E1 complex on the DNA. Each lobe had the size of a
hexamer, as required for bidirectional replication known to
occur for papillomaviruses. Preincubation of chaperone pro-
teins with E1 and ori shortens the lag time in cell-free replica-
tion. These results strongly suggest that the human chaperone
proteins facilitate the assembly of the preinitiation complex on
the HPV ori.
MATERIALS AND METHODS
Plasmids—HPV ori plasmids pUC7730–99, pUC7874–99, and
pUC7874–20 were named by inclusive nucleotides of the HPV-11 DNA
fragment cloned from the double-stranded circular genome of 7933 bp
(46). For example, pUC7730–99 spans nucleotide 7730–7933/1–99 and
contains three copies of E2BS flanking a single E1BS. pUC7874–99
also contains the same ori sequences but is shorter at the 59 sequence.
pUC7874–20 contains only one copy each for E2BS and E1BS. Each
was chosen for a different assay as described. Hsp70 and HDJ-1 ex-
pression vectors, pET-11a Hsp70 and pET-21d HDJ-1, were obtained
from Dr. Richard Morimoto (55, 56). The cDNA of HDJ-2 was obtained
from Dr. T. Mohanakumar (57). A polymerase chain reaction amplifi-
cation was used to add an NcoI site at the 59-end and a BamHI site at
the 39-end of the cDNA, which was then inserted into the multiple
cloning site of pET9d to generate the HDJ-2 expression vector, pET-9d
HDJ-2.
Protein Expression and Purification—HPV-11 E1 protein, which was
tagged at the amino terminus with a glutamate-rich epitope (EE), was
purified from recombinant baculovirus-infected Sf9 cells (42, 46). Hu-
man chaperone proteins Hsp70, HDJ-1, and HDJ-2 were expressed and
purified from E. coli BL21(DE3)pLysS as follows. Protein induction was
achieved by the addition of 0.5 mM isopropylthiogalactoside to cells at
midlog phase for 3 h at 37 °C. Cells were disrupted by sonication in lysis
buffer (20 mM HEPES-K1, pH 7.5, 1.5 mM MgCl2, 400 mM NaCl, 1 mM
dithiothreitol). The purification of Hsp70 was modified from a protocol
described previously (55). Briefly, the soluble fraction was diluted with
buffer Q (20 mM Tris-HCl, pH 7.0, 10 mM 2-mercaptoethanol) to a final
NaCl concentration of 50 mM, applied to a 10-ml Q-Sepharose column
(Bio-Rad), and eluted with a 0–500 mM NaCl gradient in buffer Q. The
fractions were analyzed by SDS-polyacrylamide gel electrophoresis, and
those containing Hsp70 were pooled and applied to an ATP-agarose
column (Sigma). Hsp70 proteins were eluted with 1 mM ATP or ADP in
buffer Q, recaptured in a 1-ml Q-Sepharose column (Econo-Pac, Bio-
Rad) and then eluted with 300 mM NaCl in Buffer Q, yielding a purity
of about 95% at 2 mg/ml. Identical procedures were used to purify
HDJ-1 and HDJ-2. Hsp40 eluted from the Q-Sepharose column with
buffer Q containing 250 mM NaCl was then diluted with buffer Q to a
final concentration of 50 mM NaCl and applied to an S-Sepharose
column (Econo-Pac, Bio-Rad). Proteins were eluted at about 150–200
mM NaCl in a 50–300 mM NaCl gradient. The final purity of Hsp40 was
over 95% at 0.3–0.5 mg/ml.
Cell-free Replication Assay—The HPV-11 origin-containing plasmid
pUC7874–99 with one E1BS and three E2BS was used as an ori
template. The conditions for cell-free replication have been described
(42, 46) with the following modifications. The amount of viral E1 protein
used was reduced due to a more active viral protein preparation, and
the 293 cell extracts were minimized to reduce the endogenous chaper-
one proteins. In the preincubation experiments, 12 ng of HPV-11 E1
protein (in 0.1 mg/ml bovine serum albumin), 40 ng of template, 4 mM
ATP were preincubated at room temperature for 15 min in the presence
or absence of 100 ng of Hsp70 and 100 ng of HDJ-1 proteins. The
balance of the replication reaction (including 8 ng of E2) and 2.5 mCi of
[a-32P]dCTP (Amersham Pharmacia Biotech) were then added, followed
by an additional incubation at 37 °C for various times. The reaction was
terminated by a stop solution containing SDS and proteinase K. Rep-
lication products were analyzed on a 0.8% agarose gel and exposed to
Hyperfilm (Amersham Pharmacia Biotech) or a PhosphorImager (Mo-
lecular Dynamics, Sunnyvale, CA).
Peptides and Antiserum—Peptides containing sequences from the J
domain of YDJ-1 protein, p21–40, p41–60, and p21–40 H34Q were as
described (28). Peptide p33–52 was synthesized by Dr. David Klapper of
the University of North Carolina at Chapel Hill. Mouse monoclonal
antibody KA2A5.6 (Hsp40/HDJ-2) and SPA-815 (Hsc70/Hsp70) were
purchased from Neomarkers and StressGen. Hybridoma cells produc-
ing monoclonal antibody against the EE epitope were obtained from Dr.
Gernot Walter (58), and the antibodies were harvested from the culture
medium and enriched by Q-Sepharose column chromatography.
EMSA—The 130-bp fragment that contained the minimal HPV-11
ori of one E1BS and one E2BS was liberated from pUC7874–20 by
digestion with EcoRI and HindIII and then 59-end labeled with T4
polynucleotide kinase (Life Technologies, Inc.) and [g-32P]ATP (Amer-
sham Pharmacia Biotech). In a 10-ml reaction mixture, 80 ng of HPV–11
EE-E1 protein were mixed with 100 ng of poly(dI-dC)zpoly(dI-dC) (Am-
ersham Pharmacia Biotech) and 20 fmol (about 6000 cpm) of labeled
DNA fragments in the binding buffer (25 mM HEPES-K1, pH 7.5, 4 mM
ATP, 7 mM MgCl2, and 1 mM dithiothreitol) with or without purified
chaperone proteins or peptides as indicated in each figure. The binding
reactions were conducted at room temperature for 20 min followed by
the addition of glutaraldehyde to a final concentration of 0.2% and
incubation for another 10 min at room temperature. For supershift
experiments, antibodies were added at 10 min into the initial incuba-
tion. The protein-DNA complexes were then analyzed in a 1.5% agarose
2 J.-S. Liu, S.-R. Kuo, T. R. Broker, and L. T. Chow, unpublished
results.
3 K. Conger, J.-S. Liu, S.-R. Kuo, L. T. Chow, and T. S.-F. Wang,
unpublished results.
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gel with 13 Tris acetate/EDTA buffer at 4 °C. Gels were dried and
exposed to Hyperfilm for 18 h or to a PhosphorImager.
Co-immunoprecipitation Assays—100 ng of purified HPV-11 EE-E1
protein, 500 ng of purified HDJ-2 protein, and 2 mg of bovine serum
albumin were incubated in the binding buffer (20 mM HEPES-K1, pH
7.5, 100 mM NaCl, 1 mM dithiothreitol) at room temperature for 20 min
before 100 ng of KA2A5.6 anti-Hsp40 antibody and 10 ml of protein-A
Sepharose 4B beads (Amersham Pharmacia Biotech) were added. After
washing with binding buffer containing 0.1% Nonidet P-40, the precip-
itates were resuspended in sample buffer (20 mM Tris-HCl, pH 7.0, 2%
SDS, 100 mM 2-mercaptoethanol) and boiled for 5 min. Proteins were
analyzed by 8% SDS-polyacrylamide gel electrophoresis, transferred to
a Hybond-C membrane (Amersham Pharmacia Biotech), and probed
with anti-EE antibody and then with peroxidase-conjugated goat anti-
mouse IgG antibody (Sigma). Signals were detected by enhanced chemi-
luminescent reactions (ECL) (Amersham Pharmacia Biotech) and ex-
posed to Hyperfilm.
Electron Microscopy—100 ng of a 600-bp PvuII DNA fragment from
the plasmid pUC7730–99 or the supercoiled plasmid was used for
electron microscopy. This plasmid was chosen because the E1BS was
approximately located at the center of the restriction fragment. The
DNA was incubated with 600 ng of E1 with or without 1.5 mg of
chaperone protein (Hsp70 or HDJ-2) or 2.8 mg of peptide p21–40 in a
buffer containing 20 mM HEPES-K1, pH 7.5, 7 mM MgCl2, 4 mM ATP,
and 10% glycerol at room temperature for 20 min. The protein-DNA
complexes were then cross-linked with 0.3% glutaraldehyde at room
temperature for 10 min and separated from free proteins by filtration
through 2-ml columns of Bio-Gel A-5m (Bio-Rad) equilibrated with 10
mM Tris-HCl, pH 7.6, 0.1 mM EDTA. The filtrate was mixed with a
buffer containing 2 mM spermidine and 0.15 M NaCl, adsorbed to glow-
charged thin carbon foils, dehydrated through a graded water-ethanol
series, and rotary shadow-cast with tungsten as described (59). Samples
were visualized in a Philips CM12 electron microscope. Micrographs
were scanned from negatives using a Nikon multiformat film scanner,
and the contrast was optimized and panels were arranged using Adobe
Photoshop. Morphometry measurements were conducted by using NIH
Image Software and a Summagraphics digitizer coupled to a Macintosh
computer programmed with software developed by J. D. G.
RESULTS
HPV-11 E1 Protein Binds to DNA as a Hexamer—The phys-
ical state of HPV-11 E1 protein was examined by electrophore-
sis through a native 5–12% gradient polyacrylamide gel. In the
presence or in the absence of ATP, the majority of the E1
protein existed as monomers, with the minority as homo-oli-
gomers as revealed by Western blot (data not shown). When
native E1 protein was adsorbed to thin carbon supports and
examined by transmission electron microscopy (EM) after neg-
ative staining, fields of particles of different sizes representing
monomers to oligomers were observed. At a high concentration
(50 mg/ml) and in the presence or absence of 4 mM ATP or
AMP-PNP, the majority of E1 was oligomeric. Large particles
of a similar size, possibly hexamers (see below), were common,
and occasionally ring-like oligomers were observed (data not
shown). For size determination, glutaraldehyde-fixed E1 pro-
tein was rotary shadow-cast on separate supports but side-by-
side with apoferritin (443 kDa). The projected areas of the large
uniform E1 particles (n 5 69) were measured and compared
with those of the apoferritin particles (n 5 23). The results
showed that E1 particles were 1.0 times the average volume of
the apoferritin (60), a value consistent with a hexamer of a
73-kDa protein.
As demonstrated previously by EMSA (46), HPV-11 E1 bind-
ing to the ori is ATP-dependent. To visualize the binding of E1
to HPV ori DNA, superhelical forms of the 2.77-kilobase pair
plasmid pUC7874–20 were incubated with E1 protein in the
presence of ATP, and the complexes were fixed with glutaral-
dehyde, filtered through Bio-Gel A-5m to remove the fixative,
and prepared for EM. A small fraction of the supercoiled DNA
became nicked upon contact with the glow-charged grids. Su-
percoiled (Fig. 1A) or open circular DNAs (Fig. 1B), each asso-
ciated with a large protein complex, were observed. The major-
ity of the complexes (73%; n 5 38) each contained a single
spherical particle of a size close to that of the free E1 hexamers
in the background. The remaining complexes (27%; n 5 14)
contained two side-by-side spherical particles on the DNA, here
termed bilobed (Fig. 1C). When a 600-bp fragment of
pUC7730–99 containing the E1BS close to the center was
incubated with E1 protein and ATP (Fig. 1, D–F), E1 particles
were observed on 20–30% of the DNA fragments. In 80–90% of
these complexes, the E1 particle was close to the center, while
10–20% showed E1 close to an end, possibly due to nonspecific
binding, since no nonspecific competitor was included as was in
EMSA (see below). Analyses of the projected size of individual
E1 protein particles on the DNA showed that they were 1.2–1.3
times the average volume of the apoferritin particles, probably
FIG. 1. Visualization of E1 protein
bound to HPV-11 origin-containing
DNA. HPV E1 protein alone (A–F) or to-
gether with HDJ-2 protein (G–I) was in-
cubated with the 2.77-kilobase pair plas-
mid pUC7874–20 containing the HPV
origin of replication (A–C) or a 600-bp re-
striction fragment thereof in which the
E1BS is located near the center (D–I) as
described under “Materials and Meth-
ods.” Following incubation, the samples
were fixed with glutaraldehyde, adsorbed
to thin carbon foils, dehydrated, air-dried,
and rotary shadow-cast with tungsten in
a high vacuum. The plasmid DNA in A is
a supercoil, while those in B and C are
relaxed circles. In the absence of HDJ-2,
the majority of the bound E1 complexes
are of a size equivalent to one hexamer,
although dihexamers (C) can be seen. In
the presence of HDJ-2 (G–I), 86% of the
complexes are a bilobed dihexamer. The
somewhat different sizes of the E1 com-
plexes on the DNA molecules reflect dif-
ferences in the amount of metal deposited
during different shadow castings. Images
are shown in reverse contrast. Bar, 500
bp.
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reflecting the inclusion of the DNA mass. Measurement of the
length of the protein-free 600-bp DNA and comparison with the
length of the DNA associated with E1 complexes showed no
consistent or significant foreshortening of the DNA due to E1
binding, suggesting that the DNA does not significantly wrap
about the protein particle. Some indication of DNA bending
about the E1 complex was noted (Fig. 1) with a bending angle
measuring 60 6 30°.
Human Chaperone Proteins Hsp70 and Hsp40 Enhance
HPV-11 E1 Protein Binding to the Origin of Replication Inde-
pendently and Additively—The sequence-specific DNA binding
activity of HPV E1 protein, compared with HPV E2 protein,
was relatively weak (46). To test whether host chaperone pro-
teins play a role in the binding of E1 to DNA, human Hsp70,
HDJ-1, and HDJ-2 proteins were purified from E. coli harbor-
ing expression vectors, and then their effects on E1-ori complex
formation were examined by EMSA (Fig. 2A). A 130-bp restric-
tion fragment containing the minimal origin with one E1BS
and one E2BS suitable for such assays was used as a substrate
in this and subsequent EMSA. Representative results are
shown. The addition of Hsp70 and Hsp40 (HDJ-1 or HDJ-2) (in
a 1:2 molar ratio) dramatically stimulated the formation of
slower migrating complexes as compared with those formed in
their absence (compare lanes 3–5 to lane 2; and lane 16 to lane
15). In the presence of 300 ng each of Hsp70 and Hsp40 (lanes
5 and 16), the amount of DNA fragment shifted was 400% of
that shifted in their absence (lanes 2 and 15). E1 was essential
for this complex formation in the presence or in the absence of
chaperones, since no slow migrating complexes were detected
when E1 was omitted (lanes 1, 12, 13, 14, 25, and 26). Further-
more, antibody to the EE tag of the E1 protein supershifted the
E1-DNA complexes (lanes 8 and 20) (46) as well as the com-
plexes formed in the presence of E1 and the chaperone proteins
(lanes 6 and 17).
We also examined E1 protein binding to the ori in the pres-
ence of each chaperone protein alone. Unexpectedly, Hsp70 or
Hsp40 independently stimulated E1-ori complex formation, al-
though not as effectively as when both were present. At 300 ng,
Hsp70 (approximately a 4:1 molar ratio of Hsp70 to E1) pro-
duced a maximal enhancement of 140% as compared with its
absence. The migration of the complexes, however, was not
altered (Fig. 2A, compare lane 10 with lane 2 and lane 23 with
lane 15). Thus, we conclude that Hsp70 is not retained in
E1-DNA complexes and that Hsp70 enhances the association of
E1 and DNA without altering the stoichiometry in the complex.
Relative to Hsp70, increasing amounts of Hsp40 alone pro-
duced a more dramatic enhancement of E1-DNA complex for-
mation. At 300 ng, the stimulation was 250% over E1 alone,
and the effect did not yet reach a plateau (data not shown). The
migration rate was slower than for complexes formed in its
absence (Fig. 2A, compare lane 11 with lane 2 and lane 24 with
lane 15) and was similar, if not identical, to that when both
chaperone proteins were present (compare lane 11 with lanes
3–5 and lane 24 with lane 16). These quantitative analyses
indicate that the stimulatory effects of Hsp70 and Hsp40 are
additive (compare lanes 10 and 11 with lane 5 and lanes 23 and
24 with lane 16) rather than synergistic, as previously observed
in other reactions with these chaperone proteins.
Hsp40 Remains Associated with the E1-DNA Complexes—
Because the HDJ-1 polyclonal antibodies interacted with E1-
DNA complexes nonspecifically (data not shown), it was not
possible to determine whether HDJ-1 remained in the com-
plexes. In contrast, neither the Hsp70- nor the HDJ-2-specific
antibodies (SPA-815 and KA2A5.6) showed any nonspecific
interaction with E1-DNA complexes (Fig. 2A, lanes 9, 21, and
22). We therefore performed supershifts by using these anti-
bodies. In the presence of Hsp70 and Hsp40, the addition of
Hsp70-specific antibody SPA-815 did not alter the mobility of
the complexes (lanes 7 and 18). Thus, Hsp70 was not associated
with the E1-ori complexes in the presence of Hsp40, nor was it
in the absence of Hsp40 (lanes 10 and 23). Most informatively,
the addition of the EE antibody, the HDJ-2-specific antibody
KA2A5.6, or both further retarded the migration rates of the
protein-DNA complexes (Fig. 2A, lanes 6, 17, and 19; data not
shown, but see Fig. 3). These data demonstrate the association
of HDJ-2 with the E1-DNA complexes. Because of the similar-
ity in the mobility of the complexes, we suggest that HDJ-1 was
also present in the slower migrating complexes. Because of the
presence of HDJ proteins in the E1-DNA complex, it was not
possible to determine whether the stoichiometry of E1 to DNA
was altered.
Since Hsp40 did not bind the DNA substrate (Fig. 2A, lanes
13 and 26), the EMSA results just described suggest a direct
interaction between Hsp40 and E1 proteins. We demonstrated
this association by co-immunoprecipitation assays (Fig. 2B). E1
was precipitated by HDJ-2-specific antibody on protein
A-Sepharose beads when HDJ-2 protein was present, but not
when HDJ-2 was omitted (Fig. 2B, compare lanes 3 and 2). This
FIG. 2. Hsp70 and Hsp40 independently enhance HPV-11 E1 protein binding to DNA. A, 10 fmol of 32P-end-labeled 130-bp DNA fragment
containing one E1BS was used as a probe in this and subsequent EMSAs. The inclusion of each reaction component is indicated by a plus sign (80
ng of E1) or in amounts (Hsp70, HDJ-1, or HDJ-2, in ng), while omission is indicated by a minus sign above each lane. Monoclonal antibody to the
epitope tag of the E1 protein (labeled EE), Hsp70 (SPA815, labeled 70), or HDJ-2 (KA2A5.6, labeled J-2) was added 10 min into the binding
reaction. Lanes 1–13 and 14–26 were separate experiments. B, co-immunoprecipitation of HDJ-2 and E1 proteins. E1 protein was immunopre-
cipitated from a mixture containing 100 ng of E1 and 500 ng of HDJ-2 by anti-HDJ-2 antibody KA2A5.6 and protein A-Sepharose beads (lane 3)
but not when HDJ-2 was omitted (lane 2). Lane 1 shows 50 ng of input E1 protein.
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protein-protein interaction was independent of the presence or
absence of ori DNA or ATP (data not shown).
J Domain Peptide Enhances E1 Binding to the DNA Ori-
gin—At higher concentrations, the yeast Hsp40 protein YDJ-1
also stimulated E1 binding to the ori (data not shown). To
investigate whether the J domain plays any role in the inter-
action between Hsp40 proteins and E1, we examined the effects
on E1 EMSA of two previously characterized peptides from
YDJ-1. Peptide p21–40 corresponds to helix II and the HPD
loop, and p41–60 spans helix III and the nonstructured tail
(27). The inclusion of 700 ng of p41–60 (Fig. 3A, lanes B) alone
or in combinations with Hsp70, HDJ-1, or HDJ-2 did not sig-
nificantly alter the E1 DNA binding activity (lanes 4, 7, 10, 13,
16, and 19) relative to complex formation in its absence (lanes
2, 5, 8, 11, 14, and 17). In contrast, the p21–40 peptide (Fig. 3A,
lanes A) alone stimulated the E1 DNA binding activity to 225%
relative to that in its absence (Fig. 3A, compare lanes 3 and 2).
A titration experiment confirmed the specific stimulation by
p21–40 and a slight repression by p41–60 at very high doses
(Fig. 3B). The effects of p21–40 in conjunction with Hsp70 and
Hsp40 were also additive, reaching an activity of 440–560%
relative to that achieved in the presence of E1 alone (compare
lanes 6 and 9 with lane 2) or about 160–200% relative to
stimulation observed in the presence of individual chaperone
proteins (compare lane 12 with lane 11, lane 15 with lane 14,
and lane 18 with lane 17). Furthermore, contrary to the inhib-
itory effect of the J domain peptide in the Hsp70/Hsp40 chap-
erone activity (28), the p21–40 peptide enhanced rather than
suppressed the stimulatory effects of Hsp70 and Hsp40, reach-
ing an activity of 530 or 675% relative to E1 alone (compare
lanes 6 and 9 to lane 2) or 150% relative to those observed in the
presence of Hsp70 and Hsp40 (compare lane 6 with lane 5 and
lane 9 with lane 8). These results support the conclusion that
the preponderance of the stimulatory effects of Hsp70 and
Hsp40 or the J peptide originates from independent activities
rather than from a collaboration between them. We believe
that the stimulatory effect of the p21–40 peptide in the pres-
ence of Hsp40 exists because the activity of Hsp40 was not yet
at a plateau at the concentrations used. Although the J peptide
increased the amount of E1-DNA complexes, it did not alter the
migration rate of the complex (Fig. 3A, compare lane 3 with
lane 2, lane 15 with lane 14, and lane 18 with lane 17) as the
full-length protein did (Fig. 2). These results demonstrate that
the stoichiometry of the E1 protein and the DNA molecule in
the complexes was not modified by the J peptide.
Both Helix II and the HPD Loop of the Hsp40 Protein Are
Required for Function—To delineate further the region in
Hsp40 proteins that binds E1, we tested the activities of two
additional peptides of YDJ-1 in parallel with the functional
p21–40. The overlapping peptide p33–52 spans the HPD loop
and the helix III region, while p21–40 H34Q contains the same
amino acid sequence as p21–40 except for a histidine to gluta-
mine change at residue 34 in the highly conserved HPD motif.
This H34Q mutation in YDJ-1 abolishes its ability to interact
with Hsp70 (28). Neither peptide alone was able to bind to the
ori DNA in the absence of E1 (data not shown). p33–52 had
little effect on E1-DNA complex formation (Fig. 4, compare
lanes 9–11 with lane 1). Stimulation of complex formation by
p21–40 was dose-dependent and, at 1.4 mg, the E1 DNA bind-
ing was stimulated to 425% (lanes 3–5). At the same dose, the
stimulatory activity of the mutated peptide p21–40 H34Q was
reduced to 220% (lanes 6–8) relative to complex formed in its
absence. These results demonstrate the importance of both the
helix II and HPD loop and support the interpretation that the
stimulatory effects observed are due to specific interactions
between the J domain and the E1 protein.
HDJ-2-specific antibody KA2A5.6 recognized peptide p21–40
but not p33–52, p41–60, or p21–40 H34Q in a dot blot assay
(data not shown, but see Fig. 5). This antibody was able to
supershift the E1-ori complex formed in the presence of p21–40
(Fig. 5, compare lane 9 with lane 3). The addition of KA2A5.6,
however, reduced the amount of complexes formed, suggesting
that the antibody partially destabilized the complexes. The
addition of both E1 and HDJ-2 antibodies further retarded the
migration of the complexes (Fig. 5, compare lane 3 with lanes 5
and 6 and lanes 11 and 12). In contrast, the presence of p41–60
had no effect on complex formation in the presence or absence
of either antibody (lanes 3, 7, 10, and 13). We conclude that,
similar to HDJ-2 and HDJ-1, p21–40 remained bound to the
E1-DNA complexes and that the helix II and HPD loop consti-
tute the minimal domain required for E1 association.
Hsp70 and Hsp40 Stimulate E1 DNA Binding via Different
Mechanisms—Binding of HPV-11 E1 proteins to the ori re-
FIG. 3. J domain peptide stimulates E1 DNA binding activity.
A, 700 ng of J domain peptide p21–40 (marked A) and the adjacent
peptide p41–60 (marked B) derived from YDJ-1 were incubated with 80
ng of E1 and 300 ng of Hsp70, HDJ-1, or HDJ-2, or combinations thereof
as indicated above lanes 3–19. Lane 1, free probe; lane 2, E1 and the
probe. B, PhosphorImager quantification of E1-DNA complexes based
on EMSA in the presence of increasing amounts of peptides p21–40
(open squares) or p41–60 (filled circles).
FIG. 4. Differential effects of J domain peptides on E1 EMSA.
E1 EMSA was conducted in the absence (lane 2) or in the presence of
increasing amounts of p21–40 (lanes 3–5), p21–40 H34Q (lanes 6–8), or
p33–52 (lanes 9–11).
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quires the presence of ATP, but the hydrolysis of ATP is not
essential. Replacement of ATP with AMP-PNP, ATPgS, or ADP
resulted in a reduced activity, while AMP conferred no activity
(47) (Fig. 6, compare lane 2 with lane 8)4 On the basis of these
observations, we tested the role of ATP hydrolysis in the
Hsp70- and Hsp40-stimulated DNA binding activity of E1. To
eliminate ATP in the Hsp70 protein preparation, the Hsp70
used in these experiments was eluted from ATP-agarose with
ADP. As shown in all of the previous experiments, in the
presence of 4 mM ATP, Hsp70, HDJ-2, or p21–40, each stimu-
lated E1 binding to DNA to about 150, 220, or 270%, respec-
tively, relative to the control (Fig. 6, compare lanes 3–5 with
lane 2), and an additive effect between Hsp70 and HDJ-2 or the
J peptide p21–40 was observed (compare lanes 6 and 7 with
lane 2), reaching an activity of 375% (lane 7). In contrast, in the
presence of 4 mM AMP-PNP, there was no stimulation by
Hsp70, while a similar extent of enhancement, which ranged
from 240 to 280%, by HDJ2 or p21–40 in the presence or
absence of Hsp70 was evident (compare lanes 9–13 with lane
8). These results demonstrate that the Hsp70 function requires
the hydrolysis of ATP, whereas the Hsp40 or the J peptide
activity does not, consistent with the notion that Hsp40 pro-
teins and the J peptide function independently of Hsp70 in this
E1-ori binding assay.
Hsp40 Stimulates the Formation of E1 Dihexamer on the
Origin DNA—We examined the effect of chaperone proteins on
E1 binding to the ori sequence by electron microscopy. Incuba-
tions were carried out with the 600-bp ori-containing DNA
fragment and E1 protein in the presence of Hsp70, Hsp40
(HDJ-2), or p21–40. The complexes were then prepared for EM
as described above. When Hsp70 or p21–40 was added, the size
or structure of the DNA-bound E1 complex was not altered by
visual inspection of the micrographs (data not shown), but the
fraction of DNA molecules containing an E1 complex appeared
to increase, in agreement with the EMSA (Figs. 2–6). Interest-
ingly, the addition of HDJ-2 resulted in a shift of the protein
complexes from single E1 hexamer on the DNA to the bilobed
complex (Fig. 1, G–I). The frequency of bilobed complexes pres-
ent on the 600-bp fragment increased to 86% (54 out of 63),
with 14% single spheres. Measurement of the projected areas of
the single spheres on the DNA and the individual halves of the
bilobed complexes showed that they were 1.2–1.3 times the
mass of the apoferritin marker. These mass measurements
were not sensitive enough to detect the possible presence of the
Hsp40 protein in the complexes. No particles were seen asso-
ciated with DNA when E1 was omitted from the incubation,
demonstrating that the bilobed particles were not composed
entirely of Hsp40. These experiments reveal that Hsp40 pro-
motes the formation of dihexamers of E1 bound to the ori.
Chaperone Proteins Reduce the Lag Time and Stimulate the
HPV-11 ori Replication in a Cell-free System—Purified HPV-11
E1 and E2 proteins and human 293 cell extracts support rep-
lication of HPV ori-containing plasmids in reactions containing
all eight nucleoside triphosphates. Western blot assays with
Hsp70/Hsc70- and Hsp40-specific antibodies showed highly
abundant chaperone proteins in the 293 cell extracts, and at-
tempts to deplete these proteins from the 293 extracts were
unsuccessful (data not shown). Besides, other related chaper-
one proteins may also have similar functions. To test whether
the stimulatory effects of the chaperone proteins on E1 binding
to the ori have any functional significance in HPV-11 ori rep-
lication, we used a reduced amount of cell extracts to minimize
the endogenous chaperone proteins and then added increasing
amounts of purified Hsp70 and HDJ-1 to the replication reac-
tions. The template pUC7874–99 with one E1BS and three
E2BS was chosen because replication efficiency increases with
the copy number of E2BS.4 The incorporation of [a-32P]dCTP
into the slowly migrating replication intermediates and fast
migrating form I product was stimulated by the addition of the
chaperone proteins (data not shown, but see Fig. 7). In a par-
allel experiment, purified chaperone proteins did not alter the
extent of replication from the SV40 ori in the presence of Tag.
This latter result is not entirely unexpected, since the Tag
already possesses a J domain, and it had a much shorter lag
time during cell-free replication than HPV ori replication in a
side by side comparison (data not shown).
In our cell-free replication assay system, there is invariably
a 45–60-min lag time before detectable [a-32P]dCTP is incor-
porated into slowly migrating replication intermediates (42).
Since the chaperone proteins enhanced the E1 binding to the
ori, we tested the hypothesis that preincubation of E1, ori
plasmid, and the chaperone proteins could shorten the lag
time. After preincubation in a buffer with ATP at room tem-
perature for 15 min, the balance of a standard replication
reaction mixture and [a-32P]dCTP was then added, and repli-
4 J.-S. Liu, S.-R. Kuo, T. R. Broker, and L. T. Chow, unpublished
results.
FIG. 5. J domain peptide p21–40 remains associated with E1-
DNA complexes. E1 EMSA was conducted in the absence (2) or in the
presence (1) of 700 ng of p21–40 or p41–60 as indicated above each
lane. In some reactions, anti-EE antibody (lanes 5–7), anti-HDJ-2 an-
tibody (lanes 8–10), or both antibodies (lanes 11–13) were added 10 min
into the reaction. Lanes 1 and 2 show the free probe and DNA binding
by E1 protein alone.
FIG. 6. Hsp70 but not HDJ-2 requires ATP hydrolysis to en-
hance E1 protein binding to DNA. E1 EMSA was performed in the
absence (2) or in the presence (1) of 300 ng of Hsp70, 300 ng of HDJ-2,
700 ng of p21–40, Hsp70 plus HDJ-2, or Hsp70 plus p21–40 as indi-
cated above each lane. Lanes 1 and 2 show the free probe and DNA
binding by E1 protein alone. The DNA binding reactions contained 4
mM ATP (lanes 2–7) or AMP-PNP (lanes 8–13). The Hsp70 protein used
in these experiments was eluted from the ATP agarose column by 1 mM
ADP.
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cation was allowed to proceed for different lengths of time
before determination. The lag time was shortened by 10–15
min (Fig. 7, squares) when compared with the control experi-
ment in which bovine serum albumin rather than chaperones
was included during preincubation (circles). The extent of rep-
lication was increased by a small amount. Both observations
were highly reproducible in repeat experiments. These results
are consistent with the interpretation that the E1-ori com-
plexes formed in the presence of the chaperone proteins were
functional and that Hsp70 and Hsp40 facilitated the binding of
E1 to the ori. We suggest that there are at least two rate-
limiting steps in the initiation of replication. One is the binding
of E1 protein to the ori and the formation of dihexamer. The
other is the recruitment of the DNA polymerase a and other
replication protein such as replication protein-A to the ori
marked by the viral proteins. The preincubation with chaper-
one proteins may have circumvented the first but not the sec-
ond rate-limiting step.
DISCUSSION
In this study, we have demonstrated that the Hsp70 and
Hsp40 chaperone proteins independently and additively en-
hance the E1 protein binding to the HPV origin of replication
via different mechanisms. The interaction between E1 and
Hsp70 is transient and requires ATP hydrolysis. Hsp70 is not
retained in the complexes, nor does it alter the ratio of E1
protein to ori DNA in the complexes as assessed by EMSA
(Figs. 2A, 3, and 6). In contrast, the function of Hsp40 does not
depend on ATP hydrolysis, and the chaperone protein remains
stably bound to the E1-DNA complexes (Figs. 2, 5, and 6). The
association of E1 and Hsp40 also occurs in the absence of ori
(Fig. 2B), and the 20-amino acid J domain peptide p21–40 from
YDJ-1 consisting of the highly conserved HPD loop and helix II
is necessary and sufficient for stimulating E1 binding to ori. A
H34Q mutation in p21–40 or in the full-length YDJ-1 protein
reduced this activity (Figs. 3 and 4 and data not shown).
One of our most intriguing findings is that the intact Hsp40
altered the physical state of the E1 bound to ori. The purified
HPV-11 E1 protein exists as a mixture of monomers and oligo-
meric complexes in a dynamic equilibrium when assayed under
a variety of conditions such as native gel electrophoresis,4
velocity sedimentation through a sucrose gradient, gel filtra-
tion,3 and EM visualization of negatively stained protein (data
not shown). Measurement of shadow-cast E1 protein showed
that the majority of the large particles had a size corresponding
to a hexamer. The majority of E1 bound to ori DNA was also
hexameric in size in the presence or absence of Hsp70 or the J
peptide (Fig. 1A, B, and D–F, and data not shown). This result
is different from a previous conclusion that BPV-1 E1 protein
binds to the ori as a trimer (61). However, more recent data
indicate the BPV-1 E1 helicase is a hexamer (62). If the HPV
E1 hexamer-ori complex is replication-competent, replication
would be unidirectional. Most interestingly, Hsp40 promoted
efficient formation of bilobed E1 complexes on ori with each
half having the mass of a single hexamer (Fig. 1, C and G–I).
Such a dihexameric E1-DNA complex would be expected of a
bidirectional replication complex, and indeed, bidirectional rep-
lication has been demonstrated for HPV-11 in laryngeal papil-
lomas and for BPV-1 in transformed cells (41, 44, 53, 63). The
low percentage of dihexamers formed in the absence of Hsp40
may be due to a small amount of J proteins of Sf9 cells that
might be present in the purified E1 preparation. We propose
that dihexamer formation is mediated by virtue of the fact that
Hsp40 functions as a dimer. Together with the binding data
with YDJ-1 peptides (Figs. 3–5), our results also suggest that
the dimerization domain of the J proteins lies partially or
completely outside the p21–40 peptide because the peptide
does not alter the E1:DNA ratio. However, since dihexamer
also formed in the absence of purified Hsp40, the possibility
cannot be ruled out that the function of Hsp40 is to stabilize E1
dihexamers that form inefficiently in the absence of Hsp40 but
that Hsp40 is not responsible for the formation of the dihex-
amer. We do not favor this interpretation, since it would sug-
gest the existence of two populations of dihexamers, one with-
out Hsp40 and another with Hsp40.
The replication-competent polyomavirus and SV40 Tag form
a dihexamer that surrounds the DNA strand at the origin or at
the replication fork (64–66). Incubation of Tag with ATP-Mg21
in the absence of ori DNA promotes the formation of hexamers
that are replication-incompetent because circular DNA cannot
thread through the preformed hexamers (66). Although the
distribution of monomers and oligomers of the HPV-11 E1 was
not altered upon the addition of ATP-Mg21 when analyzed by
gel electrophoresis,4 we assume that to become replication-
competent the multimeric E1 complexes must assemble from
monomers or smaller oligomers upon binding to the origin, but
not before. Based on this premise, we offer several possible
explanations for the stimulation of E1 binding to ori DNA by
the chaperone proteins.
The first interpretation of our observations is that the chap-
erone proteins merely help refold denatured or otherwise non-
functional E1 aggregates in the E1 protein preparation. We
consider this possibility unlikely, since Hsp70 did not alter the
proportions of monomeric and oligomeric E1 proteins in the
native gel electrophoresis, nor did the incubation with Hsp40
enhance the ATPase activities of the E1 protein (our unpub-
lished results). Furthermore, the J domain peptide p21–40,
which does not function as a chaperone and cannot dissociate
protein complexes (20), nevertheless stimulated E1 binding to
the ori (Figs. 3–6). A second possibility is that the stimulatory
effects of Hsp40 are fortuitous in that the positively charged
helix II of the J domain happens to bind to the negatively
charged EE tag of the E1 protein. This interpretation is not
supported by several observations. 1) Although the YDJ-1
H34Q protein and the p21–40 H34Q peptide contain the same
negatively charged helix II and the mutated peptide had no
known chaperone activity (28), both were able to stimulate E1
binding to ori, albeit at a reduced activity (Fig. 4 and data not
shown). 2) The binding activity of another HPV-11 E1 protein,
which is tagged by both polyhistidine and the FLAG peptide
FIG. 7. Hsp70 and HDJ-1 shorten the lag time and stimulate
HPV-11 ori replication. HPV-11 E1 protein, an efficient ori template
pUC7874–99, and ATP were preincubated at room temperature for 15
min in the presence (squares) or in the absence (circles) of 100 ng each
of purified Hsp70 and HDJ-1 proteins. 8 ng of E2, the balance of the
replication reaction mixture, and 2.5 mCi of [a-32P]dCTP were then
added at the end of the preincubation and incubated for various lengths
of time as indicated. Replication products were quantified by
PhosphorImager.
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(IBI) at the N terminus, was also similarly stimulated.4 3) The
antibodies against HDJ-2 and EE can simultaneously bind to
the complexes of E1-ori-Hsp40 or the J peptide as shown by
supershifts in EMSA (Figs. 2 and 5). 4) Neither Hsp70 nor
Hsp40 affected the binding of HPV-11 E2C purified from Sf9
cells to E2BS as a dimer (data not shown). E2C is an amino
terminus-truncated E2 protein that binds to E2BS as does the
full-length E2 protein (46). These results strongly suggest that
the interactions between E1 and chaperone proteins have a
considerable degree of specificity and, in particular, that Hsp40
does not function as a conventional chaperone protein.
The third interpretation, which we favor, is that chaperones
are integral to the pathway of forming replication-competent
dihexameric E1 complexes on the origin. In support of this
hypothesis, preincubation of E1 protein with ori in the presence
of Hsp70 and Hsp40 and ATP for 15 min correspondingly
reduced the lag time and increased the extent of replication
(Fig. 7). We propose that the Hsp70 chaperone protein may
somehow alter the conformation of monomeric or oligomeric E1
protein or that it may possibly dissociate the preformed oli-
gomers to facilitate reassembly on the ori as a hexamer, a role
somewhat related to the chaperone functions proposed for the
assembly of bacterial or phage replication initiators on each
respective ori (7, 11, 14).
However, the manner by which HPV E1 protein takes ad-
vantage of the attributes of host HDJ proteins has not been
described before. In its normal role as co-chaperone, the amino-
terminal portion of Hsp40 containing the J domain interacts
with Hsp70, whereas the carboxyl terminus binds the sub-
strate (20, 67). In contrast, the J domain of Hsp40 binds to the
E1 protein independent of Hsp70 (Figs. 2B and 3–6). Although
our data do not rule out the possibility that the carboxyl-
terminal peptide binding domain of the Hsp40 also interacts
with the E1 protein, the occupancy by E1 of the J domain may
have prevented further interaction between Hsp40 and Hsp70
and abolished the synergistic effect between these two chaper-
one proteins. All of the results presented indicate that Hsp40
protein does not function as a conventional co-chaperone of
Hsp70 during E1 binding to ori. Rather, E1 is bound to Hsp40
in its capacity as an ATPase. To our knowledge, this is the first
example of an association of Hsp40 via the J domain with an
ATPase that is not a chaperone protein. This interpretation
explains the independent and additive effects of Hsp70 and
Hsp40 on the binding of E1 to the ori. It is also consistent with
a reduced association between E1 and the p21–40 H34Q pep-
tide or the full-length YDJ1 H34Q protein (Fig. 4 and data not
shown), in agreement with the structural information that
suggests helix II and the HPD motif to be the minimal se-
quences required for Hsp40 in interaction with Hsp70 (25).
Thus, the effects of Hsp40 on E1 binding to ori appear to be
2-fold. First, the highly conserved J domain interacts with E1
and alone can stimulate or stabilize E1 binding to DNA. Sec-
ond, Hsp40 functions as an assembly factor for the formation of
dihexamer E1 on the ori. The dihexameric E1-DNA complex
may have an increased stability relative to a single hexameric
E1-DNA complex, accounting for the much more significant
stimulatory effect of Hsp40 on E1 binding to ori compared with
the effects of Hsp70 or the J peptide (Fig. 3).
In conclusion, using EMSA, EM, and cell-free replication, we
have demonstrated that the human chaperone proteins Hsp70
and particularly Hsp40, including HDJ-1 and HDJ-2, play im-
portant roles in promoting the binding of an E1 hexamer to and
the formation of an E1 dihexamer on the HPV-11 origin of
replication prior to interactions with the host DNA polymerase
to initiate DNA replication. At this juncture, we do not know
whether these particular host proteins or other related mem-
bers actually participate in these interactions in vivo. Thus,
unlike the SV40 or polyomaviruses, which contain an endoge-
nous J domain in their T antigens, the papillomavirus utilizes
the host Hsp40 to assist the E1 protein function.
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